iPSC derived cell therapies: A Deep Dive in Targets for Cancer IO

This webinar, the sixth of the 2022 Targets for Cancer IO: A Deep Dive Series, will discuss the research and clinical findings behind induced pluripotent stem cell-derived cell therapies. Basic, clinical and translational researchers in academia and industry and members of the investment community are the target audience of this series.

Moderators:

• Kalle Malmberg, MD, PhD – Oslo University Hospital
• Jeffrey S. Miller, MD – University of Minnesota

Faculty:

• Ran Jing, PhD - Boston Children's Hospital
  
• Sjouke van der Stegen, PhD - Memorial Sloan Kettering, The Michael Sadelain Lab